Review and perspective on adjuvant and neoadjuvant immunotherapies in NSCLC

Postoperative patients have risk recurring, even for completed resected early stage non-small-cell lung cancer (NSCLC). To control the recurrence rate, neoadjuvant and adjuvant therapies have been applied widely in clinical practice; however, neoadjuvant and adjuvant immunotherapy clinical trials on...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Chengxiang, He, Yayi, Xia, Haoran, Zhang, Helin, Zhang, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735538/
https://www.ncbi.nlm.nih.gov/pubmed/31564915
http://dx.doi.org/10.2147/OTT.S218321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735538/
https://www.ncbi.nlm.nih.gov/pubmed/31564915
http://dx.doi.org/10.2147/OTT.S218321

Ejemplares similares